Survival in overweight and underweight children undergoing hematopoietic stem cell transplantation

M White1, A J Murphy, A Hallahan

  • 1Department of Nutrition and Dietetics, Royal Children's Hospital, Herston, Queensland, Australia. Melinda_White@health.qld.gov.au

Insights

Overweight children undergoing hematopoietic stem cell transplantation have reduced survival rates. Nutritional status impacts outcomes for pediatric cancer patients, with overweight status posing a significant risk post-transplant.

Area of Science:

  • Pediatric oncology
  • Hematopoietic stem cell transplantation
  • Nutritional science

Background:

  • Nutritional status is increasingly recognized as a factor influencing outcomes in pediatric cancer patients.
  • Understanding the impact of pre-transplant nutritional status on survival is crucial for optimizing patient care.

Purpose of the Study:

  • To investigate the association between pre-transplant nutritional status and overall survival in children undergoing hematopoietic stem cell transplantation.
  • To determine if weight categories (underweight, ideal weight, overweight) correlate with post-transplant survival rates.

Main Methods:

  • Retrospective audit of 113 pediatric patients undergoing autologous or allogeneic hematopoietic stem cell transplant.
  • Patients categorized into underweight, ideal weight, and overweight based on percent ideal body weight.
  • Overall post-transplant survival analyzed across weight categories, adjusting for relevant covariates.

Main Results:

  • Overweight patients (36%) demonstrated significantly lower survival rates compared to ideal-weight patients (Hazard Ratio 1.91).
  • Underweight patients (13%) did not show a statistically significant increase in mortality compared to ideal-weight patients (Hazard Ratio 1.47).
  • Key factors adjusted for included age, sex, donor source, conditioning therapy, and year of transplant.

Conclusions:

  • Pre-transplant overweight status is associated with decreased survival in children following hematopoietic stem cell transplantation.
  • Maintaining an ideal body weight prior to transplantation may be beneficial for improving survival outcomes in pediatric patients.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...